Abstract:
Methods for producing glycosylated and methylated resveratrol in a genetically engineered cell, by bioconversion,and in vitro are disclosed herein.
Abstract:
Methods for producing glycosylated and methylated resveratrol in a genetically engineered cell, by bioconversion,and in vitro are disclosed herein.
Abstract:
Methods and constructs for RNA-guided targeting of heterologous functional domains such as transcriptional activators to specific genomic loci.
Abstract:
Die Erfindung stellt Mittel und Verfahren zur Modifizierung der 5'-Kappe von RNA bereit, beispielsweise für Isolierungs- und Analysenzwecke. In einem Aspekt stellt die Erfindung modifizierte Enzyme, nämlich modifizierte Trimethylguanosinsynthasen 2 aus Giardia lamblia (GlaTGS2) bereit, deren enzymatische Aktivität dahingehend geändert ist, dass sie AdoMet-Analoga im Vergleich zum Wildtypenzym besser als Kofaktoren nutzen können.
Abstract:
The present disclosure relates, according to some embodiments, to compositions, organisms, systems, and methods for expressing a gene product in a plant (e.g., a monocot) using a promoter operable in one or more plant tissues and/or cells. In some embodiments, an isolated nucleic acid may comprise an expression control sequence having the sequence of nucleotides 1-4726 of SEQ ID NO: 1, wherein the expression control sequence has stem-regulated and/or defense-inducible promoter activity in at least one monocot (e.g., at least two monocots).
Abstract translation:根据一些实施方案,本公开涉及使用可在一个或多个植物组织和/或细胞中可操作的启动子在植物(例如单子叶植物)中表达基因产物的组合物,生物,系统和方法。 在一些实施方案中,分离的核酸可以包含具有SEQ ID NO:1的核苷酸1-4726的序列的表达调控序列,其中所述表达控制序列在至少一个中具有干细胞调节和/或防御诱导型启动子活性 单子叶植物(例如,至少两个单子叶植物)。
Abstract:
Methods and genetic sequences are described for use in determining the diagnosis, subtype, prognosis, and disease course of high-grade gliomas, such as glioblastoma multiforme. One such method includes determining increased expression of at least one gene on a chromosome segment in cells of the glioma, the segment being 17:57,851,812-17:57,973,757; 7: 127,892,509-7: 127,947,649; 12:33,854-12:264,310; or 19:33,329,393-19:35,322,055; and estimating, based on the expression, a predicted length of survival, a probability of survival, or a predicted response to a therapy for the glioma.
Abstract:
This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode methyltransferase polypeptides from a Papaver somniferum cultivar; and uses in the production of noscapine and identification of poppy cultivars that include the genes that comprise said nucleic acid molecules.
Abstract:
Methods and compositions related to the use of Mobile Element Insertions and their adjacent genomic sequences. Methods using MEIs as markers for cellular proliferation, as targets for pharmaceuticals, as markers for tissue fingerprinting and in related methods and compositions are disclosed herein. Methods and compositions relate to the detection, treatment and ongoing monitoring of cell proliferation events, cancer, and deleterious effects of mobile elements in aging, and to the selection, use and monitoring of the success of treatment regimens to address these conditions.
Abstract:
The present invention provides a method of determining whether cytosine residues present at a predetermined positions within a single strand of a double stranded DNA of known sequence are methylated as well as compounds for carrying out this method.